计算机断层尿路造影后输尿管镜在上尿路尿路上皮癌管理中的影响
该研究前瞻性收集并回顾性分析244例有术前计算机断层尿路造影(CTU)的输尿管镜病例,评估CTU与输尿管镜诊断上尿路尿路上皮癌的一致性及对治疗指征的影响。结果显示输尿管镜阳性率随CTU分级变化,且37/76例(48.1%)的治疗指征在输尿管镜后发生改变。
要点
- CTU阳性、可疑、不太可能和阴性时输尿管镜阳性率分别为93%、62.3%、55.6%和48%。
- CTU充盈缺损阳性预测值87.7%,肾积水79.7%,狭窄65.6%,增厚69.6%。
- 输尿管镜后48.1%病例的治疗指征改变,与CTU一致性仅Kappa=0.31。
核心结论
- CTU与输尿管镜互补用于上尿路尿路上皮癌诊断工作需进一步评估。
研究设计与样本
- 前瞻性收集2015年至2018年11月共244例有术前CTU的输尿管镜病例,回顾性分析。
主要发现
- 输尿管镜阳性率在CTU阳性、可疑、不太可能和阴性组分别为107/115(93%)、48/77(62.3%)、15/27(55.6%)和12/25(48%)。
- 细胞组织学确认164/182(90.1%)病例。
- CTU充盈缺损、狭窄、增厚和肾积水的阳性预测值分别为87.7%(121/138)、65.6%(21/32)、69.6%(64/92)和79.7%(59/74)。
- 多因素分析显示充盈缺损(95%CI 2.76-11.5,OR 5.63,p<0.0001)或肾积水(1.04-6.18,OR 2.52,p=0.04)与输尿管镜结果相关。
- CTU和输尿管镜均阳性病例中,45/107(42.1%)病灶在尺寸(20/107)、数量(14/107)或部位(11/107)上存在差异。
关键数值与推荐
- 基于2020 EAU指南和患者临床数据记录输尿管镜前后的治疗指征。
- 输尿管镜后37/76(48.1%)病例的治疗指征改变(Kappa=0.31)。
- 内镜管理、输尿管切除术和肾输尿管切除术的指征确认率分别为17/28(60.7%)、11/20(55%)和11/28(39.2%)。
临床怎么用
- CTU和输尿管镜联合评估可影响上尿路尿路上皮癌的治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We report the reliability of computerized tomography urography and ureteroscopy in the diagnosis and management of upper tract urothelial carcinoma. MATERIALS AND METHODS: From 2015 to November 2018 we prospectively collected and retrospectively analyzed 244 cases of ureteroscopy with available preoperative computerized tomography urography. Computerized tomography urography was categorized as positive, suspicious, unlikely and negative. Correspondence between imaging, ureteroscopy and histology was analyzed. The therapeutic indication, based on 2020 EAU Guidelines and patient clinical data, was recorded before and after ureteroscopy. Cohen's Kappa was used for agreement analysis. Logistic regression was used for prediction of positive ureteroscopy. RESULTS: Ureteroscopy was positive for upper tract urothelial carcinoma in 107/115 (93%), 48/77 (62.3%), 15/27 (55.6%) and 12/25 (48%) cases with positive, suspicious, unlikely and negative computerized tomography urography, respectively. On cytohistology the result was confirmed in 164/182 (90.1%) cases. The positive predictive value of a filling defect, stenosis, thickening and hydronephrosis on computerized tomography urography was 87.7% (121/138 cases), 65.6% (21/32), 69.6% (64/92) and 79.7% (59/74), respectively. On multivariate analysis a filling defect (95% CI 2.76-11.5, OR 5.63, p <0.0001) or hydronephrosis (1.04-6.18, OR 2.52, p=0.04) was associated with ureteroscopy outcome. Among cases with positive computerized tomography urography and ureteroscopy, the lesions differed in dimensions (20/107), number (14/107) and site (11/107), for a total of 45/107 (42.1%) cases. The indication of elective treatment changed after ureteroscopy in 37/76 (48.1%) cases (Kappa=0.31), as 17/28 (60.7%), 11/20 (55%) and 11/28 (39.2%) indications were confirmed for endoscopic management, ureterectomy and nephroureterectomy, respectively. CONCLUSIONS: The complementary use of computerized tomography urography and ureteroscopy in the diagnostic workup of upper tract urothelial carcinoma should be evaluated.
引用
- Gallioli A, Territo A, Mercadé A, et al. The Impact of Ureteroscopy following Computerized Tomography Urography in the Management of Upper Tract Urothelial Carcinoma. J Urol. 2020. PMID: 32935620. doi:10.1097/JU.0000000000001370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。